# Goldman Sachs (GS) — InvestMoat Analysis _Last analyzed: May 2026_ _Asset class: equity · Canonical page: https://investmoat.com/stocks/gs_ ## Scores | Dimension | Score (0–100) | | --- | --- | | Moat durability | 69 | | Growth trajectory | 63 | | Valuation | 56 | | **Composite** | **60** | | **Recommendation** | **Speculative Buy** | Scores are computed deterministically from this asset’s data by the InvestMoat formula (see https://investmoat.com/llms.txt for methodology). Scores are not directly comparable across asset classes. ## Key stats - **Ticker:** GS - **Market Cap:** ~$267B ## Moat Goldman Sachs is the dominant global investment bank — #1 or #2 in M&A advisory, equity underwriting, and equities trading — with a culture and client roster built over 155 years that no peer has been able to replicate. The moat is the network: every blue-chip CEO has a Goldman banker, every large fund pays Goldman commissions, and Goldman sees the deal flow first. ### The Capital Markets Network Moat Goldman's competitive position rests on **client relationships, league-table dominance, and trading scale** — a virtuous network where each strengthens the others: - **League-Table Network Effects:** Goldman has held the #1 or #2 position in global M&A advisory for the better part of three decades. CEOs hire the bank with the most relevant experience and the deepest cross-border network — and Goldman, by virtue of having advised on the most deals, has the most relevant experience. This is a self-reinforcing loop: more mandates beget more references beget more mandates. Q1 2026 IB fees rebounded sharply as M&A activity normalized. - **Equities Franchise and Trading Scale:** Q1 2026 delivered record Equities revenues within Global Banking & Markets ($12.74B segment revenue, +19% YoY). Goldman's prime brokerage, derivatives, and program trading franchises see institutional flow that smaller competitors cannot match — and the data from that flow informs market-making across products. Trading scale is a moat that compounds with electronification, as fixed costs (tech, risk, compliance) spread over more volume. - **Asset & Wealth Management Pivot:** AUS hit a record $3.65T in Q1 2026, with management-fee growth providing increasingly visible recurring revenue. The pivot toward AWM (alternatives, private credit, ultra-high-net-worth wealth) reduces earnings cyclicality, supports a higher multiple, and leverages Goldman's institutional brand into a fee-based franchise that the market values at 15-20x rather than 8-10x. **Moat verdict:** Goldman has a durable network and brand moat in capital markets, but the franchise is more cyclical and relationship-driven than the universal-bank or alts peer set. AI accelerates banker productivity and pitch creation, modestly widening Goldman's lead in advisory, but cannot substitute for CEO trust. Hold; size up at trough multiples (~1.3x TBV). ## Growth Q1 2026 revenue +14% YoY to $17.23B, EPS $17.55 (+24%, second-highest quarter ever), ROE 19.8%. Global Banking & Markets +19% to $12.74B with record Equities; AWM at record $3.65T AUS. Goldman's earnings power is back near the cyclical highs of 2021 — the question is durability. Forward growth depends on sustained M&A recovery and AWM compounding; capital markets activity remains structurally cyclical. - **Revenue CAGR estimate:** 5-8% - **Primary type:** market share - **Margin trend:** expanding - **Key risk (high):** Capital-markets cyclical reversion in 2026-2027 — a tariff-driven M&A freeze could cut IB fees 30-40% and compress ROE toward 12-13%. - **Drivers:** - Global Banking & Markets — GBM revenue +19% YoY to $12.74B; record Equities (accelerating) - Asset & Wealth Management — AUS record $3.65T, on track to cross $4T (stable) - M&A advisory — IB fees recovering off 2022-2024 trough (accelerating) - **Score derivation:** Base 60 + 10 for record Q1 prints and AWM compounding - 8 for cyclical-peak earnings and reversion risk = 62 ## Valuation At ~$917, GS trades at ~13x 2026E EPS (~$70) and ~1.7x tangible book — the high end of its historical range, reflecting a cyclical earnings peak. The stock has rallied ~82% over the past year and sits between base ($930) and bull ($1,100) targets, with limited margin of safety. A normalization in capital markets activity could pressure both EPS and the multiple. **Fair value:** $930 — Goldman is a great franchise but a cyclical stock. The 1.7x TBV multiple is appropriate at peak ROE (~19%) but compresses to ~1.2-1.3x at trough. The right way to own GS is to buy when capital markets are out of favor (TBV multiple <1.3x), not at cyclical highs. Wait for a better entry; trim into strength. ## Price scenarios ### Bear — $650 Tariff-driven recession freezes M&A and IPO markets, trading volumes compress, IB fees fall 30-40%, and the multiple de-rates to trough TBV. - M&A pipeline freezes; investment banking fees fall 35% from 2026 peak; capital markets activity contracts as in 2022-2023 - Trading revenues normalize off cyclical highs; ROE falls to 12-13%; 2027 EPS compresses to ~$50 - Multiple compresses to ~1.3x TBV — implying ~$650 ### Base — $930 Capital markets activity remains constructive but cools modestly off Q1 2026 highs; AWM continues to compound; ROE settles at ~15-17% through-cycle. - M&A and IB fees grow modestly off elevated 2026 base; Equities/FICC normalize but stay above pre-2024 levels - AWM AUS crosses $4T; management fees provide visible recurring revenue; AWM segment margins expand - EPS reaches ~$72 in 2027; at 13x and ~1.7x TBV, fair value ~$930 ### Bull — $1,100 Multi-year M&A super-cycle plays out, AWM accelerates, the consumer drag fully runs off, and the market re-rates GS toward an asset-light franchise multiple. - Sustained M&A super-cycle drives IB fees toward 2021 peak; ECM/DCM activity remains elevated - AWM crosses $4.5T AUS; alternatives and ultra-HNW wealth drive 15%+ AWM growth and meaningful margin expansion - Multiple re-rates to ~1.9x TBV on durability of AWM and IB recovery — implying ~$1,100 --- InvestMoat is an open-source research and education framework. Nothing here is financial advice. Past performance does not guarantee future results.